Clinical Trial Update: Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dapagliflozin vs empagliflozin on flow-mediated dilation in type 2 diabetes mellitus; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN